• Melittin: Bioactive Peptide Solutions for Cancer Signal Tran

  2026-05-17

  Melittin, sourced from APExBIO, empowers researchers to modulate G protein-coupled pathways with precision—enabling advanced apoptosis and cancer biology assays. Its dual effect on Gs and Gi proteins, high solubility, and peer-reviewed validation set a new standard for reproducibility and workflow optimization.

• Curcumin Prevents Endothelial Pyroptosis via NLRP3 Inhibitio

  2026-05-16

  Yuan et al. (2022) reveal that curcumin protects human umbilical vein endothelial cells (HUVECs) from hydrogen peroxide–induced pyroptosis by inhibiting NLRP3 inflammasome activation. Their work highlights a mechanistic link between oxidative stress, pyroptosis, and endothelial dysfunction, suggesting new strategies for targeting inflammatory pathways in atherosclerosis.

• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor-S

  2026-05-15

  This study introduces a patient-derived gastric cancer assembloid model that integrates matched tumor organoids with stromal cell subpopulations, more accurately recapitulating the cellular heterogeneity and microenvironment of primary tumors. The research demonstrates how stromal components influence gene expression and drug responses, offering a robust platform for preclinical testing and personalized therapy optimization.

• MDV3100 (Enzalutamide) in Prostate Cancer: Applied Workflows

  2026-05-15

  MDV3100 (Enzalutamide) empowers advanced prostate cancer research through robust apoptosis induction and precise androgen receptor pathway modulation. This guide details experimental workflows, troubleshooting strategies, and novel insights from recent literature, equipping researchers to maximize rigor and reproducibility.

• MHY1485: mTOR Activator for Advanced Autophagy and Follicle

  2026-05-14

  MHY1485 enables robust, reproducible mTOR pathway activation and precise autophagy inhibition for cell signaling and ovarian follicle development research. With optimized workflows and troubleshooting strategies, MHY1485 empowers high-impact investigations across metabolism, cancer, and reproductive biology.

• Biotin-16-UTP: Elevating RNA Detection and Purification Work

  2026-05-14

  Biotin-16-UTP enables precise, high-yield RNA labeling for advanced detection, purification, and interaction studies. Seamlessly integrated into in vitro transcription, this reagent streamlines complex workflows and supports the interrogation of RNA-protein dynamics—empowering researchers in cancer biomarker and functional lncRNA analysis.

• Applied Neuroinflammation Research with CHI3L1-IN-5 (Compoun

  2026-05-13

  CHI3L1-IN-5 (Compound Z17) uniquely enables researchers to block CHI3L1-mediated NF-κB inflammatory signaling and restore astrocyte function in Alzheimer’s models. This guide translates recent structural and pharmacological advances into actionable workflows, troubleshooting, and comparative advantages for neurodegeneration research.

• RG108: Precision DNA Methyltransferase Inhibitor for Epigene

  2026-05-13

  RG108 stands out as a potent, non-nucleosidic DNA methyltransferase inhibitor, enabling precise and reversible epigenetic modulation in both cancer research and stem cell differentiation workflows. Its unique mechanism, supported by robust experimental data, positions RG108 as a leading tool for researchers aiming to reactivate silenced genes and interrogate DNA methylation dynamics with confidence.

• Z-VDVAD-FMK: Advancing Caspase-2 Pathway Inhibition in Antiv

  2026-05-12

  Explore how Z-VDVAD-FMK, a potent caspase-2 inhibitor, enables advanced dissection of apoptosis and antiviral pathways. This in-depth article connects mechanistic insights with novel applications, offering a unique perspective beyond cancer research.

• Biotin-16-UTP: Enabling Next-Gen RNA Interactomics in HCC

  2026-05-12

  This thought-leadership article explores the mechanistic and translational impact of biotin-labeled uridine triphosphate—specifically APExBIO’s Biotin-16-UTP—in advancing RNA detection, purification, and interactome mapping, with a spotlight on lncRNA RNASEH1-AS1 in hepatocellular carcinoma (HCC). Integrating cutting-edge research and workflow recommendations, the article provides strategic guidance for translational researchers seeking to bridge molecular insights with clinical innovation.

• Thioguanine: Mechanistic Innovations in Antitumor and Antivi

  2026-05-11

  Explore Thioguanine’s dual mechanisms as an antitumor and antiviral agent, with a focus on its unique inhibition of DNA methyltransferase 1 and EV71 replication. This article offers fresh, mechanistic insights for advanced assay design and clinical translation.

• DGLA-Induced Ferroptosis via ACSL4 Rewires Lipid Metabolism

  2026-05-11

  This study uncovers how exogenous dihomo-γ-linolenic acid (DGLA) induces ferroptosis in acute myeloid leukemia (AML) cells through ACSL4-mediated lipid metabolic reprogramming. The findings highlight a promising metabolic vulnerability in AML, offering new avenues for overcoming chemotherapy resistance.

• Probing Therapeutic Peptide Aggregation with 1H NMR and AA-M

  2026-05-10

  This study systematically examines the aggregation behavior of structurally related therapeutic peptides, including degarelix, using 1H NMR spectroscopy and all-atom molecular dynamics simulations. The findings clarify how subtle sequence differences and counterion interactions influence aggregation, offering methodological advances for peptide drug development and formulation.

• Excessive Calpain Impairs Offspring Cognition via BDNF/TrkB

  2026-05-09

  This study reveals that maternal non-obstetric surgery during pregnancy triggers excessive calpain activation in the developing rat hippocampus, leading to BDNF/TrkB pathway dysregulation and impaired cognitive outcomes in offspring. Pharmacological calpain inhibition with MDL 28170 or TrkB pathway stimulation partially rescues neuronal structure and function, highlighting new avenues for neuroprotection research.

• Sodium Ascorbate: Applied Workflows for Cancer Cell Assays

  2026-05-09

  Sodium Ascorbate, the mineral salt form of ascorbic acid, enables reproducible induction of intracellular ROS and selective necrotic tumor cell death, advancing glioblastoma multiforme research and broader cancer models. Here, we detail data-driven protocols, real-world troubleshooting, and how APExBIO’s Sodium Ascorbate uniquely addresses experimental challenges in oncology workflows.

8659 records 15/578 page Previous Next First page 上5页 1112131415 下5页 Last page